{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:18:15Z","timestamp":1775737095103,"version":"3.50.1"},"reference-count":28,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"abstract":"<jats:p>ABSTRACT  BACKGROUND: Cholangiocarcinoma (CCA) is a rare neoplasm, with high mortality, originating in the bile ducts. Its incidence is higher in Eastern countries due to the endemic prevalence of liver parasites. Factors such as metabolic syndrome, smoking, and pro-inflammatory conditions are also linked to the disease. Clinical features include asthenia, abdominal pain, cholestasis, and increased serum levels of CEA and CA19-9.  AIMS: The aim of this study was to evaluate CCA prevalence, survival, and potential prognostic and therapeutic implications in a patient cohort and assess correlations with clinical laboratory data and possible associated risk factors.  METHODS: This is a retrospective study of the clinical and histological data of patients diagnosed with CCA at Santa Casa de Miseric\u00f3rdia in Porto Alegre, Brazil, between 2016 and 2021.  RESULTS: There was a 56% prevalence of CCA in women, with intrahepatic localization in 55.4% of cases and unifocality in 85.6% of patients. The mean age of the patients was 63 years (26\u201389 years), with a mean tumor size of 5.5 cm. The median survival time was 7 months (0 to &gt;50). CA19-9 was altered in 81% of patients, whereas GOT\/GPT was altered in 62.5% and gamma-glutamyl transferase\/alkaline phosphatase\/bilirubin in 69.1% of patients. Mortality was higher among patients with extrahepatic CCA.  CONCLUSION: Risk factors such as smoking, cholecystectomy, cirrhosis, intrahepatic lithiasis, and transplantation should be considered individually by the attending physician for radiological monitoring and incidental discovery of the neoplasm. Lack of timely identification by the attending physician can delay diagnosis, increasing mortality.<\/jats:p>","DOI":"10.1590\/0102-6720202400057e1851","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:31:28Z","timestamp":1736767888000},"source":"Crossref","is-referenced-by-count":2,"title":["CHOLANGIOCARCINOMA: EPIDEMIOLOGY, HISTOPATHOLOGY, AND POTENTIAL PROGNOSTIC AND THERAPEUTIC IMPLICATIONS IN A COHORT FROM A REFERENCE CENTER IN SOUTHERN BRAZIL"],"prefix":"10.1590","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7792-9526","authenticated-orcid":false,"given":"Jo\u00e3o Pedro Pattussi","family":"BERTINATTI","sequence":"first","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-4506","authenticated-orcid":false,"given":"Josenel Maria Barcelos","family":"MAR\u00c7AL","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-9325","authenticated-orcid":false,"given":"Eduardo","family":"CAMBRUZZI","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-9171","authenticated-orcid":false,"given":"Dido Eliphas","family":"LE\u00c3O DE ALENCAR","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"e0120574","DOI":"10.1371\/journal.pone.0120574","article-title":"Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States","volume":"10","author":"Altekruse SF","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41379-019-0290-0","article-title":"Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma","volume":"32","author":"Balitzer D","year":"2019","journal-title":"Mod Pathol"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz B","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley PJ","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cld.2020.04.005","article-title":"Cholangiocarcinoma: diagnosis and management","volume":"24","author":"Buckholz AP","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/liv.13998","article-title":"Classifications and misclassification in cholangiocarcinoma","volume":"39","author":"Cardinale V","year":"2019","journal-title":"Liver Int"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements O","year":"2020","journal-title":"J Hepatol"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.3390\/jcm11123417","article-title":"The clinical relevance of hypothyroidism in patients with solid non-thyroid cancer: a tantalizing conundrum","volume":"11","author":"Deligiorgi MV","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/17512433.2022.2093714","article-title":"The continuum of care of anticancer treatment-induced hypothyroidism in patients with solid non-thyroid tumors: time for an intimate collaboration between oncologists and endocrinologists","volume":"15","author":"Deligiorgi MV","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","article-title":"Intrahepatic cholangiocarcinoma","volume":"28","author":"El-Diwany R","year":"2019","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1590\/0102-672020210002e1618","article-title":"Protocol for liver transplantation in hilar cholangiocarcinoma","volume":"34","author":"Ernani L","year":"2022","journal-title":"Arq Bras Cir Dig"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI63212","article-title":"Cholangiocarcinomas can originate from hepatocytes in mice","volume":"122","author":"Fan B","year":"2012","journal-title":"J Clin Invest"},{"issue":"Suppl. 16","key":"ref13","doi-asserted-by":"crossref","first-page":"CT283","DOI":"10.1158\/1538-7445.AM2020-CT283","article-title":"Abstract CT283: KEYNOTE-966: A randomized, double-blind, placebo-controlled, phase 3 study of pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract carcinoma","volume":"80","author":"Finn RS","year":"2020","journal-title":"Cancer Res"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/cncr.32803","article-title":"Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012","volume":"126","author":"Florio AA","year":"2020","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2632010X20925045","DOI":"10.1177\/2632010X20925045","article-title":"Precursor lesions of cholangiocarcinoma: a clinicopathologic review","volume":"13","author":"Geramizadeh B","year":"2020","journal-title":"Clin Pathol"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/17474124.2021.1946393","article-title":"Metabolic disorders and the risk of cholangiocarcinoma","volume":"15","author":"Ghidini M","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"e1607","DOI":"10.1590\/0102-672020210003e1607","article-title":"Does age influence in endoscopic therapeutic success on the biliary tract?","volume":"34","author":"Hybner L","year":"2022","journal-title":"Arq Bras Cir Dig"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1389289","DOI":"10.1155\/2019\/1389289","article-title":"Precursors to cholangiocarcinoma","volume":"2019","author":"Hucl T","year":"2019","journal-title":"Gastroenterol Res Pract"},{"issue":"Suppl 1","key":"ref19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan SA","year":"2019","journal-title":"Liver Int"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.path.2018.02.005","article-title":"Cholangiocarcinoma","volume":"11","author":"Krasinskas AM","year":"2018","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford KE","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"ref22","first-page":"285","article-title":"Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period","volume":"19","author":"Mihalache F","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"issue":"19","key":"ref23","doi-asserted-by":"crossref","first-page":"E3806","DOI":"10.1073\/pnas.1619416114","article-title":"Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands","volume":"114","author":"Nakagawa H","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9935","key":"ref24","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava N","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma \u2013 evolving concepts and therapeutic strategies","volume":"15","author":"Ilyas SI","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.20517\/2394-5079.2021.130","article-title":"Epidemiology of cholangiocarcinoma","volume":"8","author":"Turati F","year":"2022","journal-title":"Hepatoma Res"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/hbsn.2016.11.04","article-title":"Pathology of intrahepatic cholangiocarcinoma","volume":"6","author":"Vijgen S","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/hep.31200","article-title":"Insights into the origin of intrahepatic cholangiocarcinoma from mouse models","volume":"72","author":"Zhu Y","year":"2020","journal-title":"Hepatology"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":["COLANGIOCARCINOMA: EPIDEMIOLOGIA, HISTOPATOLOGIA E POTENCIAIS IMPLICA\u00c7\u00d5ES PROGN\u00d3STICAS E TERAP\u00caUTICAS EM COORTE DE UM CENTRO DE REFER\u00caNCIA DO SUL DO BRASIL"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-67202024000100334&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:31:39Z","timestamp":1736767899000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202024000100334&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":28,"alternative-id":["S0102-67202024000100334"],"URL":"https:\/\/doi.org\/10.1590\/0102-6720202400057e1851","relation":{},"ISSN":["2317-6326","0102-6720"],"issn-type":[{"value":"2317-6326","type":"electronic"},{"value":"0102-6720","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e1851"}}